Literature DB >> 11307626

Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method.

Y Yang1, H P Schmitt.   

Abstract

A graph method was employed to analyze the spatial neuronal patterns of nuclear grays of the pontine tegmentum with ascending aminergic projections to the forebrain in 12 cases of frontotemporal dementia (FTD). The nuclear grays examined were the nucleus centralis superior (NCS), a part of the nucleus raphae dorsalis (NRD), and the locus coeruleus (LC). The results were compared with 30 cases of Alzheimer's disease (AD) and 35 non-demented controls. In addition to the graph evaluations, neuronal cytoplasmic inclusion bodies were stained by silver impregnation and ubiquitin (Ub) and tau immunohistochemistry. The FTD cases showed a significant, 40%, decline in number of neurons in the NCS and NRD, while the LC was spared. The magnitude of neuronal loss matched that of AD where, by contrast, the LC was also severely changed. Amyloid deposition and Alzheimer neurofibrillary tangles occurred in the aminergic nuclei almost exclusively in AD and, to a minor extent, in some aged controls. No cytoplasmic inclusion bodies were found in the aminergic nuclei of the FTD cases. However, 6 cases had Ub-positive but tau-negative neuronal inclusions in the hippocampal dentate fascia and in layer 2 of the prefrontal isocortex, and 3 showed clinical and histological signs of motor neuron disease. Our results suggest that the serotoninergic raphe nuclei with ascending projections to the forebrain, but not the LC, become directly or indirectly involved in frontotemporal dementia both with and without motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307626     DOI: 10.1007/s004010000293

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

Review 1.  Treatment approaches to symptoms associated with frontotemporal degeneration.

Authors:  Tiffany W Chow
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

2.  REM sleep behavior disorder in a patient with frontotemporal dementia.

Authors:  Daniele Lo Coco; Chiara Cupidi; Alfredo Mattaliano; Valentina Baiamonte; Sabrina Realmuto; Emanuele Cannizzaro
Journal:  Neurol Sci       Date:  2011-07-13       Impact factor: 3.307

Review 3.  [Frontotemporal dementias].

Authors:  K Witt; G Deuschl; T Bartsch
Journal:  Nervenarzt       Date:  2013-01       Impact factor: 1.214

Review 4.  Therapy and clinical trials in frontotemporal dementia: past, present, and future.

Authors:  Richard M Tsai; Adam L Boxer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

Review 5.  Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Authors:  Gil D Rabinovici; Bruce L Miller
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

6.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

7.  Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats.

Authors:  Izzettin Hatip-Al-Khatib; Katsunori Iwasaki; Yoshitaka Yoshimitsu; Takashi Arai; Nobuaki Egashira; Kenichi Mishima; Tomoaki Ikeda; Michihiro Fujiwara
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 8.  Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.

Authors:  Gregory A Jicha
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

9.  Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  Neurol Sci       Date:  2011-06-07       Impact factor: 3.307

10.  Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.

Authors:  D M Bowen; A W Procter; D M A Mann; J S Snowden; M M Esiri; D Neary; P T Francis
Journal:  Psychopharmacology (Berl)       Date:  2007-11-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.